Baxter International | BAX - Net Income

Stock Price
18.49
Daily Change
0.33 1.82%
Monthly
17.03%
Yearly
-39.44%
Q2 Forecast
17.77

Baxter International reported $-1.13B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Fresenius EUR 361M 17M Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Laboratory Of America USD 164.7M 96.4M Dec/2025
Masimo USD 68.3M 168.7M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Quest Diagnostics USD 251M 6M Mar/2026
Smith & Nephew USD 293M 79M Dec/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Terumo JPY 32.65B 2.4B Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025